Interactions between alcohol intake and the polymorphism of rs708272 on serum high-density lipoprotein cholesterol levels in the Guangxi Hei Yi Zhuang population

Alcohol

Volumn 42, Issue 7, 2008, Pages 583-591

  Zhou, Yijiang ^a,b   Yin, Ruixing ^a   Deng, Yaju ^a   Li, Yiyang ^a   Wu, Jinzhen ^a  

^a First Affiliated Hospital   (China)

^b Guangxi Provincial Corps Hospital   (China)

Author keywords

Alcohol consumption; Cholesteryl ester transfer protein; Gene; High density lipoprotein cholesterol; Polymorphism

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 54749087512     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2008.08.004     Document Type: Article

References (64)

1. Agarwal D.P. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol 37 (2002) 409-415
2. Agellon L.B., Quinet E.M., Gillette T.G., Drayna D.T., Brown M.L., and Tall A.R. Organization of the human cholesteryl ester transfer protein gene. Biochemistry 29 (1990) 1372-1376
3. Arai H., Yamamoto A., Matsuzawa Y., Saito Y., Yamada N., Oikawa S., et al. Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J. Atheroscler. Thromb. 12 (2005) 240-250
4. Arca M., Montali A., Ombres D., Battiloro E., Campagna F., Ricci G., et al. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Clin. Genet. 60 (2001) 374-380
5. Barter P.J., and Rye K.A. High density lipoproteins and coronary artery disease. Atherosclerosis 121 (1996) 1-12
6. Bermudez O.I., Velez-Carrasco W., Schaefer E.J., and Tucker K.L. Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes. Am. J. Clin. Nutr. 76 (2002) 1214-1221
7. Berns M.A., de Vries J.H., and Katan M.B. Increase in body fatness as a major determinant of changes in serum total cholesterol and high density lipoprotein cholesterol in young men over a 10-year period. Am. J. Epidemiol. 130 (1989) 1109-1122
8. Boekholdt S.M., Sacks F.M., Jukema J.W., Shepherd J., Freeman D.J., McMahon A.D., et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111 (2005) 278-287
9. Brousseau M.E., O'Connor Jr. J.J., Ordovas J.M., Collins D., Otvos J.D., Massov T., et al. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1148-1154
10. Bruce C., Chouinard Jr. R.A., and Tall A.R. Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport. Annu. Rev. Nutr. 18 (1998) 297-330
11. Castelli W.P., Doyle J.T., Gordon T., Hames C.G., Hjortland M.C., Hulley S.B., et al. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet 2 (1977) 153-155
12. Choudhury S.R., Ueshima H., Kita Y., Kobayashi K.M., Okayama A., Yamakawa M., et al. Alcohol intake and serum lipids in a Japanese population. Int. J. Epidemiol. 23 (1994) 940-947
13. Cohen J.C., Wang Z., Grundy S.M., Stoesz M.R., and Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest 94 (1994) 2377-2384
14. Cooperative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 23 (2002) 5-10
15. Corella D., Saiz C., Guillén M., Portolés O., Mulet F., González J.I., et al. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis 152 (2000) 367-376
16. Craig W.Y., Palomaki G.E., and Haddow J.E. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. B. M. J. 298 (1989) 784-788
17. Criqui M.H., Cowan L.D., Tyroler H.A., Bangdiwala S., Heiss G., Wallace R.B., et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the lipid research clinics follow-up study. Am. J. Epidemiol. 126 (1987) 629-637
18. Cuchel M., Wolfe M.L., deLemos A.S., and Rader D.J. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians. Atherosclerosis 163 (2002) 169-174
19. De Oliveira E Silva E.R., Foster D., McGee Harper M., Seidman C.E., Smith J.D., Breslow J.L., and Brinton E.A. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 102 (2000) 2347-2352
20. Drayna D., Jarnagin A.S., McLean J., Henzel W., Kohr W., Fielding C., et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327 (1987) 632-634
21. Durstine J.L., Grandjean P.W., Davis P.G., Ferguson M.A., Alderson N.L., and DuBose K.D. Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med. 31 (2001) 1033-1062
22. Freeman D.J., Griffin B.A., Holmes A.P., Lindsay G.M., Gaffney D., Packard C.J., et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler. Thromb. 14 (1994) 336-344
23. Freeman D.J., Packard C.J., Shepherd J., and Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin. Sci. 79 (1990) 575-581
24. Freeman D.J., Samani N.J., Wilsona V., McMahon A.D., Braund P.S., Cheng S., et al. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland coronary prevention study. Eur. Heart J. 24 (2003) 1833-1842
25. Fumeron F., Betoulle D., Luc G., Behague I., Ricard S., Poirier O., et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 96 (1995) 1664-1671
26. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79 (1989) 8-15
27. Hannuksela M.L., Liinamaa M.J., Kesaniemi Y.A., and Savolainen M.J. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 110 (1994) 35-44
28. Hannuksela M., Marcel Y.L., and Kesaniemi Y.A. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J. Lipid Res. 33 (1992) 737-744
29. Heller D.A., de Faire U., Pedersen N.L., Dahlén G., and McClearn G.E. Genetic and environmental influences on serum lipid levels in twins. N. Engl. J. Med. 328 (1993) 1150-1156
30. Hodoglugil U., Williamson D.W., Huang Y., and Mahley R.W. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin. Genet. 68 (2005) 118-127
31. Hong S.H., Kim Y.R., Song J., and Kim J.Q. Genetic variations of cholesterol ester transfer protein gene in Koreans. Hum. Biol. 73 (2001) 815-821
32. Hsu L.A., Ko Y.L., Hsu K.H., Ko Y.H., and Lee Y.S. Genetic variations in the cholesteryl ester transfer protein gene and highdensity lipoprotein cholesterol levels in Taiwanese Chinese. Hum. Genet. 110 (2002) 57-63
33. Kauma H., Savolainen M.J., Heikkila R., Rantala A.O., Lilja M., Reunanen A., et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum. Genet. 97 (1996) 156-162
34. Kondo I., Berg K., Drayna D., and Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin. Genet. 35 (1989) 49-56
35. Mann J.I. Dietary effects on plasma LDL and HDL. Curr. Opin. Lipidol. 8 (1997) 35-38
36. McPherson R., Grundy S.M., Guerra R., and Cohen J.C. Allelic variation in the gene encoding the cholesteryl ester transfer protein is associated with variation in the plasma concentrations of cholesteryl ester transferprotein. J. Lipid Res. 37 (1996) 1743-1748
37. Meguro S., Takei I., Murata M., Hirose H., Takei N., Mitsuyoshi Y., et al. Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis 156 (2001) 151-156
38. Mensink R.P., and Katan M.B. Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N. Engl. J. Med. 321 (1989) 436-441
39. Miltiadous G., Hatzivassiliou M., Liberopoulos E., Bairaktari E., Tselepis A., Cariolou M., et al. Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic population. Nutr. Metab. Cardiovasc. Dis. 15 (2005) 219-224
40. Mitchell R.J., Earl L., Williams J., Bisucci T., and Gasiamis H. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum. Biol. 66 (1994) 13-25
41. Ordovas J.M., Cupples L.A., Corella D., Otvos J.D., Osgood D., Martinez A., et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1323-1329
42. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Skoumas J., Zeimbekis A., Papaioannou I., et al. Effect of leisure time physical activity on blood lipid levels: the ATTICA study. Coron. Artery Dis. 14 (2003) 533-539
43. Park H.S., Yun Y.S., Park J.Y., Kim Y.S., and Choi J.M. Obesity, abdominal obesity, and clustering of cardiovascular risk factors in South Korea. Asia Pac. J. Clin. Nutr. 12 (2003) 411-418
44. Park K.W., Choi J.H., Kim H.K., Oh S., Chae I.H., Kim H.S., et al. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans. Clin. Genet. 63 (2003) 31-38
45. People's Republic of China-United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. Circulation 85 (1992) 1083-1096
46. Rimm E.B., Williams P., Fosher K., Criqui M., and Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. B. M. J. 319 (1999) 1523-1528
47. Ruixing Y., Fengping H., Shangling P., Dezhai Y., Weixiong L., Tangwei L., et al. Prevalence of hyperlipidemia and its risk factors for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations. J. Investig. Med 54 (2006) 191-200
48. Ruixing Y., Guangqin C., Yong W., Weixiong L., Dezhai Y., and Shangling P. Effect of the 3'APOB-VNTR polymorphism on the lipid profiles in the Guangxi Hei Yi Zhuang and Han populations. BMC Med. Genet. 8 (2007) 45-58
49. Ruixing Y., Jiaqiang D., Dezhai Y., Weixiong L., Shangling P., Jinzhen W., et al. Effects of demographic characteristics, health-related behaviors and lifestyle factors on the prevalence of hypertension for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han Populations. Kidney Blood Press. Res. 29 (2006) 312-320
50. Ruixing Y., Limei Y., Yuming C., Dezhai Y., Weixiong L., Muyan L., et al. Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens. Res. 29 (2006) 423-432
51. Ruixing Y., Rongshan L., Weixiong L., Dezhai Y., and Shangling P. Effect of the MTP-493 G/T polymorphism on the lipid profiles of the Guangxi Hei Yi Zhuang and Han populations. Eur. J. Lipid Sci. Technol. 108 (2006) 561-568
52. Ruixing Y., Yong W., Guangqin C., Weixiong L., Dezhai Y., and Shangling P. Lipoprotein lipase gene polymorphism at the PvuII locus and serum lipid levels in Guangxi Hei Yi Zhuang and Han populations. Clin. Chem. Lab. Med 44 (2006) 1416-1421
53. Ruixing Y., Yuming C., Shangling P., Fengping H., Tangwei L., Dezhai Y., et al. Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations. Arch. Med. Res. 37 (2006) 787-793
54. Ruixing Y., Yuming C., Shangling P., Fengping H., Tangwei L., Dezhai Y., et al. Effects of demographic, dietary, and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. Eur. J. Cardiovasc. Prev. Rehabil. 13 (2006) 977-984
55. Savolainen M.J., and Kesaniemi Y.A. Effects of alcohol lipoproteins in relation to coronary heart disease. Curr. Opin. Lipidol. 6 (1995) 243-250
56. Sharrett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sorlie P.D., Catellier D., et al. Atherosclerosis Risk in Communities Study Group. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions. Circulation 104 (2001) 1108-1113
57. Steinmetz J., Boerwinkle E., Gueguen R., Visvikis S., Henny J., and Siest G. Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis 92 (1992) 219-227
58. Sy R.G., Cutiongco E.M., Punzalan F.E., Santos R.S., Geronimo F.R., and Tangco R.V. Human cholestryl ester transfer protein (TaqIB) polymorphism among Filipinos with cardiovascular risk factors. J. Atheroscler. Thromb. 14 (2007) 116-121
59. Tenkanen H., Koshinen P., Kontula K., Aalto-Setälä K., Mänttäri M., Manninen V., et al. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum. Genet. 87 (1991) 574-578
60. Thu N.N., Mai T.T., Ohmori R., Kuroki M., Van Chuyen N., Hung N.T., et al. Effect of the cholesteryl ester transfer protein genotypes on plasma lipid and lipoprotein levels in Vietnamese children. Pediatr. Res. 58 (2005) 1249-1253
61. Tsujita Y., Nakamura Y., Zhang Q., Tamaki S., Nozaki A., Amamoto K., et al. The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample. Atherosclerosis 191 (2007) 199-205
62. Vohl M.C., Lamarche B., Pascot A., Leroux G., Prud'homme D., Bouchard C., et al. Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with features of the insulin resistance syndrome. Int. J. Obes. Relat. Metab. Disord 23 (1999) 918-925
63. Yasue H., Hirai N., Mizuno Y., Harada E., Itoh T., Yoshimura M., et al. Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ. J. 70 (2006) 8-13
64. Zhang X., Sun Z., Zheng L., Li J., Liu S., Xu C., et al. Prevalence of dyslipidemia and associated factors among the hypertensive rural Chinese population. Arch. Med. Res. 38 (2007) 432-439